| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 180 |
| 1 | ALENDRONATE SODIUM | 173 |
| 2 | ADALIMUMAB | 156 |
| 3 | UPADACITINIB | 132 |
| 4 | DENOSUMAB | 118 |
| 5 | IBRUTINIB | 115 |
| 6 | METHOTREXATE | 85 |
| 7 | METHOTREXATE SODIUM | 81 |
| 8 | LEVOTHYROXINE SODIUM | 77 |
| 9 | OMEPRAZOLE MAGNESIUM | 75 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DENOSUMAB-BMWO | 1 | 0.0303 |
| 1 | PENICILLIN G POTASSIUM | 14 | 0.0192 |
| 2 | DEXTROMETHORPHAN HBR 20MG GUAIFENESIN 400MG | 1 | 0.0164 |
| 3 | GUAIFENESIN, DEXTROMETHORPHAN HBR | 1 | 0.0152 |
| 4 | DEXTROMETHORPHAN HBR AND GUAIFENESIN | 1 | 0.0133 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 31 | 0.0112 |
| 6 | GUAIFENESIN AND DEXTROMETHORPHAN HBR | 1 | 0.0105 |
| 7 | HYPOCHLOROUS ACID | 1 | 0.0093 |
| 8 | PENICILLIN G | 20 | 0.0085 |
| 9 | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | 1 | 0.0081 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 210 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 183 |
| 2 | Kinase Inhibitor [EPC] | 158 |
| 3 | Corticosteroid [EPC] | 138 |
| 4 | Janus Kinase Inhibitor [EPC] | 134 |
| 5 | RANK Ligand Inhibitor [EPC] | 119 |
| 6 | Benzodiazepine [EPC] | 84 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 84 |
| 8 | Vitamin C [EPC] | 80 |
| 9 | Proton Pump Inhibitor [EPC] | 78 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 6 | 0.0016 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 2 | 0.0010 |
| 5 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 7 | Janus Kinase Inhibitor [EPC] | 134 | 0.0008 |
| 8 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 9 | Sympathomimetic-like Agent [EPC] | 23 | 0.0007 |